£100m Health Tech Fund Targets UK Home and Community Care Innovation

A new £100 million-backed investment fund aims to accelerate UK health technology companies scaling into real-world care settings. 

New Investment Targets Scale Up Gap in UK Care Technology

A major new investment fund focused on UK health technology could have important implications for home care, community health services and the wider social care landscape.

Apposite Capital has launched Apposite Healthcare Growth I, backed by a £100 million commitment from the British Business Bank. The funding is the Bank’s largest commitment to date and is aimed at addressing a longstanding issue in the UK innovation pipeline: the shortage of scale-up capital.

While early-stage funding for digital health startups has grown in recent years, many companies struggle to secure the investment needed to expand their products into widespread use across the NHS and social care services. This funding gap has limited the impact of innovations designed to support care delivery in homes and communities.

Supporting Technologies for Care Closer to Home

The new fund will invest in companies developing medical technologies, diagnostics and digital health platforms. Many of these innovations have direct relevance to the UK care sector, particularly as services increasingly shift towards prevention and care at home.

Digital care records, remote monitoring tools and virtual care platforms are already reshaping how services are delivered. However, scaling these solutions remains a challenge, especially across a fragmented care system.

By focusing on growth-stage companies, the fund aims to help technologies move beyond pilot phases and into routine use. This could support wider adoption of home care technology that enables providers to monitor patients remotely, manage care plans digitally and respond more quickly to changing needs.

Sam Gray, Managing Partner at Apposite Capital, said the fund would back companies capable of improving healthcare outcomes while helping them “accelerate their growth” and “commercialise transformative technologies”.

Strengthening Links Between Research and Care Delivery

A key element of the initiative is its collaboration with the National Institute for Health and Care Research (NIHR), which works closely with the National Health Service and academic institutions.

The partnership is designed to help companies navigate clinical validation, regulatory requirements and evidence generation, areas that are often barriers to adoption in both NHS and social care settings.

For providers and commissioners, stronger evidence can make it easier to invest in new technologies with confidence. It also increases the likelihood that innovations are aligned with real-world care needs, rather than remaining theoretical or limited to trials.

Professor Lucy Chappell, Chief Executive of NIHR, said the collaboration would help ensure research translates into “tangible benefits for patients and the public”.

Implications For Care Providers and Local Authorities

For care providers and local authorities, the availability of better-funded technology companies could improve access to more reliable and scalable solutions.

One of the challenges in the UK care sector is fragmentation. Social care services are delivered by a mix of organisations with varying levels of digital maturity, making it difficult for technology suppliers to scale effectively.

Growth-stage investment can help companies build the infrastructure, support services and integration capabilities needed to operate at scale. This, in turn, may lead to more consistent and accessible care technology across the sector.

Christine Hockley of the British Business Bank highlighted the need for larger funds capable of supporting high-growth companies, with the aim of strengthening the UK’s technology ecosystem and attracting further investment.

A Step Towards A More Mature Digital Health Ecosystem

The launch of Apposite Healthcare Growth I reflects a broader shift in the UK towards supporting not just innovation, but also implementation.

For the care sector, this is particularly important. Technologies that improve care coordination, enable early intervention and support independent living are increasingly central to policy ambitions, yet often struggle to move beyond small-scale deployment.

By targeting the scale-up phase, the fund could help build a more mature care technology market, where proven solutions are able to reach more providers and service users.

The £100 million investment into Apposite Healthcare Growth I represents a significant effort to address the UK’s scale-up funding gap in health technology.

For home care providers, NHS community services and local authorities, the potential benefits include greater access to robust digital health and care technology solutions. These tools could support more efficient, personalised and proactive care in community settings.